Author Correction: Evolution of HER2-low expression from primary to recurrent breast cancer

QR Code

Author Correction: Evolution of HER2-low expression from primary to recurrent breast cancer

Saved in:

Bibliographic Details
Main Authors:	Federica Miglietta, Gaia Griguolo, Michele Bottosso, Tommaso Giarratano, Marcello Lo Mele, Matteo Fassan, Matilde Cacciatore, Elisa Genovesi, Debora De Bartolo, Grazia Vernaci, Ottavia Amato, PierFranco Conte, Valentina Guarneri, Maria Vittoria Dieci
Format:	article
Language:	EN
Published:	Nature Portfolio 2021
Subjects:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Online Access:	https://doaj.org/article/5a209eb810624fa3b79e6ac0b52cc517
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Impact of estrogen receptor levels on outcome in non-metastatic triple negative breast cancer patients treated with neoadjuvant/adjuvant chemotherapy
by: Maria Vittoria Dieci, et al.
Published: (2021)

Immune microenvironment and intrinsic subtyping in hormone receptor-positive/HER2-negative breast cancer
by: Gaia Griguolo, et al.
Published: (2021)

Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade
by: Fara Brasó-Maristany, et al.
Published: (2020)

Immune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancer
by: G. Griguolo, et al.
Published: (2021)

The role of HER2 and HER3 in HER2-amplified cancers beyond breast cancers
by: Avisek Majumder, et al.
Published: (2021)

Preclinical therapy of disseminated HER-2⁺ ovarian and breast carcinomas with a HER-2-retargeted oncolytic herpesvirus.
by: Patrizia Nanni, et al.
Published: (2013)

Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression
by: Veronica Giusti, et al.
Published: (2021)

Remembering Sally Engle Merry: Her scholarship and her legacy
by: Anne Griffiths
Published: (2021)

Assessment of HER2 testing patterns, HER2+ disease, and the utilization of HER2-directed therapy in early breast cancer
by: Stenehjem DD, et al.
Published: (2014)

The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial
by: Laura Pizzuti, et al.
Published: (2021)

ZOË BOCCABELLA’S CALABRIAN CHAPTER IN MEZZA ITALIANA AS A SYMBOLIC ELIMINATION OF SOUTHERNESS FROM HER OWN DIASPORIC SELF
by: Teresa Di Somma, et al.
Published: (2017)

An Islam of Her Own
by: Fatima Seedat
Published: (2013)

Her majesty the transaction
by: Gaćeša Radmila
Published: (2021)

In her own time
by: Flora Jung
Published: (2018)

Her voice lingers on and her memory is strategic: effects of gender on directed forgetting.
by: Hwajin Yang, et al.
Published: (2013)

May Her Likes Be Multiplied
by: Nancy L. Stockdale
Published: (2002)

Dual HER2 blockade in the neoadjuvant and adjuvant treatment of HER2-positive breast cancer
by: Advani P, et al.
Published: (2015)

Robust and accurate digital measurement for HER2 amplification in HER2 equivocal breast cancer diagnosis
by: Yuefeng Wang, et al.
Published: (2017)

Mismatch repair deficiency predicts response to HER2 blockade in HER2-negative breast cancer
by: Nindo B. Punturi, et al.
Published: (2021)

Synthetic lethality between HER2 and transaldolase in intrinsically resistant HER2-positive breast cancers
by: Yi Ding, et al.
Published: (2018)

The translator and his/her language/culture
by: Reinhold Utri
Published: (2021)

Narrative of Her Life: Mary Jemison
Published: (2017)

Rara and Her Bedtime Story Journey
by: Rudi Suherman
Published: (2020)

Utility of Serum HER-2/ neu in Prediction of Tissue HER-2 /neu Status of Primary Breast Cancer
by: Maral Mokhtari, et al.
Published: (2021)

HER2 + breast cancers evade anti-HER2 therapy via a switch in driver pathway
by: Alison E. Smith, et al.
Published: (2021)

La escolástica española y la génesis de la filosofía latinoamericana. Alonso Briceño metafísica e individualidad /
by: Cacciatore, Giuseppe
Published: (2006)

Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer
by: Yunhua Liu, et al.
Published: (2018)

Spontaneous epithelial-mesenchymal transition and resistance to HER-2-targeted therapies in HER-2-positive luminal breast cancer.
by: David Lesniak, et al.
Published: (2013)

THE EFFECT OF THE DOE WEIGHT ON HER REPRODUCTIVE EFFICIENY
by: Mohammad Ebrahim Ahmed, et al.
Published: (2021)

REVIEW: Paying with her life for telling it like it is
by: Seumas Phelan
Published: (2004)

In her own words: Melanesian women in media
by: Faith Valencia-Forrester, et al.
Published: (2020)

Quantification of EGFR-HER2 Heterodimers in HER2-Overexpressing Breast Cancer Cells Using Liquid-Phase Electron Microscopy
by: Diana B. Peckys, et al.
Published: (2021)

HER2 phosphorylation is maintained by a PKB negative feedback loop in response to anti-HER2 herceptin in breast cancer.
by: Merel Gijsen, et al.
Published: (2010)

Simulation of a flash-flood event over the Adriatic Sea with a high-resolution atmosphere–ocean–wave coupled system
by: Antonio Ricchi, et al.
Published: (2021)

TROUGH HER EYES. THE ADVENTURES OF MARGARET MCKELVY BIRD
by: Martinic,Mateo
Published: (2017)

Letter to her Husband, Absent Upon Publick Employment
Published: (2017)

HER2 breast cancer therapies: a review
by: Conleth G Murphy, et al.
Published: (2009)

Bevacizumab in the treatment of HER2-negative breast cancer
by: Vito Lorusso
Published: (2008)

Financial recovery as bankruptcy proceedings or result of her conduct
by: O. YU. Rudakova, et al.
Published: (2017)

Fundamentos de derecho argentino libro de casos /
by: Genovesi, Luis Mariano
Published: (2010)